IEX •
Healthcare •
Biotechnology •
Quote as of 06/23/2026 15:59
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeIEX
Market Capitalization499.39 mln
Float55.95 mln
Earnings Date07/30/2026
Piotroski F-Score
2
/ 9
Weak
Beneish M-Score
-0.68
Highly suspicious
1-Year Forecast
14.80
Transformational upside
Relative Strength
93
/ 100
Top performer
Debt / Equity
0.02
Debt-free
ROE
-41.69
Deeply negative
Business Description
Arvinas is a New Haven-based biotechnology company that develops medicines designed to eliminate harmful proteins from the body by working with the body's own built-in waste disposal process. Its pipeline covers a range of serious conditions, including Parkinson's disease, several types of cancer, and breast cancer. The company works alongside major pharmaceutical partners such as Pfizer, Roche, and Bayer to advance its treatments toward patients.
